JLJonathan O. Lipton

Jonathan O. Lipton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan O. Lipton has a total of 116 co-authors. Here are the top co-authors by number of shared publications:

  • Hannah Hawks-Mayer

    Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children’s Hospital, Boston, MA 02115, USA

    3 shared publications
  • Fortunate F. Chifamba

    Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children’s Hospital, Boston, USA

    2 shared publications
  • Aja Pragana

    Department of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, USA

    1 shared publication
  • Alec J. Walker

    F. M. Kirby Neurobiology Center, Boston Children’s Hospital, Boston, MA, USA

    1 shared publication
  • Alexander Rotenberg

    Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children’s Hospital, Boston, MA 02115, USA

    1 shared publication
  • Alfonso Alfini

    National Center on Sleep Disorder Research, Division of Lung Diseases, NHLBI, Bethesda, USA

    1 shared publication

Latest Publications

  • Open Access

    Brain border-associated macrophages rhythmically scavenge amyloid-beta and regulate vascular amyloid pathology

    by Helena J. Barr, Sydney K. Caldwell, Justin M. Colville-Reimertz, Constanze Depp, Alec J. Walker, Jasmin Patel, Samuel E. Marsh, Anushree S. Gupte, Maximillian Hingerl, Sang-O Park, et al.

  • Open Access

    Circadian rhythms in pediatric neurocritical care: interfaces and opportunities

    by W. Michael Babinchak, Jonathan O. Lipton

    Neurological disorders represent a disproportionate fraction of pediatric intensive care unit (PICU) admissions, accounting for approximately one quarter of all critically ill children. These conditions—including traumatic brain injury, hypoxic–ischemic encephalopathy, stroke, infectious and inflammatory disorders, epilepsy, and disorders of consciousness—are frequently accompanied by profound disruption of circadian rhythms. The circadian timekeeper is a fundamental biological system that coordinates physiology across scales, from molecular and cellular processes to systemic functions such as metabolism, immunity, thermoregulation, endocrine signaling, vascular regulation, synaptic physiology, and sleep–wake cycling. In the PICU and neonatal ICU (NICU) environments, multiple factors—including continuous or irregular lighting, noise, frequent clinical interventions, sedation, altered feeding schedules, and the pathophysiology of neurological injury itself—conspire to destabilize circadian organization. We summarize these contributing factors into pathways of critical care circadian desynchrony (C3D). This review examines the intersection between circadian biology and pediatric neurocritical care. We first summarize the molecular and systems-level architecture of the circadian system and distinguish circadian rhythms from sleep–wake state regulation. We then outline the development of sleep and circadian rhythms in the fetus, neonate, infant and child, emphasizing that pediatric circadian biology cannot be treated as a simple extension of adult neurology and chronobiology. We consider how the PICU and NICU environments disrupt circadian biology and discuss how circadian dysregulation manifests across common neurological conditions encountered in pediatric critical care including hypoxic–ischemic encephalopathy (HIE), traumatic brain injury (TBI), stroke, infection and autoimmune encephalitides, epilepsy, delirium, and status dystonicus. Emerging literature suggests that disturbances of circadian outputs—including hormone secretion, metabolism, immune signaling, thermoregulation, sleep–wake cycling, autonomic regulation, and gene expression—may influence neurological injury progression, recovery trajectories, and long-term neurodevelopmental outcomes. We review current methods used to measure sleep and circadian rhythms in critically ill children, including polysomnography, electroencephalography, actigraphy, biomarker-based approaches, and emerging physiological metrics derived from continuous monitoring. Finally, we discuss potential clinical strategies aimed at restoring circadian alignment in the PICU environment, including environmental modification, sedation-aware care, pharmacologic chronobiotics, time-structured nutrition, and chronotherapy. Together, we offer a conceptual framework that centralizes circadian desynchronization in pediatric neurocritical care as an under-explored, potentially targetable modifier of neurological injury and recovery in pediatric critical illness. Integrating circadian biology into pediatric neurocritical care may provide new opportunities for biomarker development, therapeutic intervention, prognostication, and personalized chronomedicine.

  • Sleep and circadian rhythms in cardiovascular resilience: mechanisms, implications, and a Roadmap for research and interventions

    by Brooke Aggarwal, Yunling Gao, Alfonso Alfini, Ali Azarbarzin, Ron C. Anafi, Kelly Glazer Baron, Victoria L. Bautch, Nicole Bowles, Josiane L. Broussard, Marishka Brown, et al.

    The interaction between sleep, circadian rhythms and cardiovascular resilience is a crucial yet underexplored research area with important public health implications. Disruptions in sleep and circadian rhythms exacerbate hypertension, diabetes mellitus and obesity, conditions that are increasingly prevalent globally and increase the risk of cardiovascular disease. A National Heart, Lung, and Blood Institute workshop examined these connections, as well as the emerging concept of cardiovascular resilience as a dynamic and multifaceted concept spanning molecular, cellular and systemic levels across an individual’s lifespan. The workshop emphasized the need to expand the focus from solely understanding whether and how sleep and circadian rhythm disturbances contribute to disease, to also exploring how healthy sleep and aligned circadian rhythms can increase cardiovascular resilience. To develop a Roadmap towards this goal, workshop participants identified key knowledge gaps and research opportunities, including the need to integrate biological, behavioural, environmental and societal factors in sleep and circadian health with cardiovascular research to identify therapeutic targets. Proposed interventions encompass behavioural therapies, chronotherapy, lifestyle changes, organizational policies and public health initiatives aimed at improving sleep and circadian health for better cardiovascular outcomes. Future cross-disciplinary research and translation of discoveries into public health strategies and clinical practices could improve cardiovascular resilience across the lifespan in all populations.


  • Open Access

    Synaptic BMAL1 phosphorylation controls circadian hippocampal plasticity

    by Ilaria Barone, Nicole M. Gilette, Hannah Hawks-Mayer, Jonathan Handy, Kevin J. Zhang, Fortunate F. Chifamba, Engie Mostafa, Erin M. Johnson-Venkatesh, Yan Sun, Jennifer M. Gibson, et al.

    The time of day strongly influences adaptive behaviors like long-term memory, but the correlating synaptic and molecular mechanisms remain unclear. The circadian clock comprises a canonical transcription-translation feedback loop (TTFL) strictly dependent on the BMAL1 transcription factor. We report that BMAL1 rhythmically localizes to hippocampal synapses in a manner dependent on its phosphorylation at Ser 42 [pBMAL1(S42)]. pBMAL1(S42) regulates the autophosphorylation of synaptic CaMKIIα and circadian rhythms of CaMKIIα-dependent molecular interactions and LTP but not global rest/activity behavior. Therefore, our results suggest a model in which repurposing of the clock protein BMAL1 to synapses locally gates the circadian timing of plasticity.


  • Open Access

    Defining diurnal fluctuations in mouse choroid plexus and CSF at high molecular, spatial, and temporal resolution

    by Ryann M. Fame, Peter N. Kalugin, Boryana Petrova, Huixin Xu, Paul A. Soden, Frederick B. Shipley, Neil Dani, Bradford Grant, Aja Pragana, Joshua P. Head, et al.

    Transmission and secretion of signals via the choroid plexus (ChP) brain barrier can modulate brain states via regulation of cerebrospinal fluid (CSF) composition. Here, we developed a platform to analyze diurnal variations in male mouse ChP and CSF. Ribosome profiling of ChP epithelial cells revealed diurnal translatome differences in metabolic machinery, secreted proteins, and barrier components. Using ChP and CSF metabolomics and blood-CSF barrier analyses, we observed diurnal changes in metabolites and cellular junctions. We then focused on transthyretin (TTR), a diurnally regulated thyroid hormone chaperone secreted by the ChP. Diurnal variation in ChP TTR depended on Bmal1 clock gene expression. We achieved real-time tracking of CSF-TTR in awake TtrmNeonGreen mice via multi-day intracerebroventricular fiber photometry. Diurnal changes in ChP and CSF TTR levels correlated with CSF thyroid hormone levels. These datasets highlight an integrated platform for investigating diurnal control of brain states by the ChP and CSF.


  • Open Access

    Keeping an eye on circadian time in clinical research and medicine

    by Elizabeth B. Klerman, Allison Brager, Mary A. Carskadon, Christopher M. Depner, Russell Foster, Namni Goel, Mary Harrington, Paul M. Holloway, Melissa P. Knauert, Monique K. LeBourgeois, et al.

    Background: Daily rhythms are observed in humans and almost all other organisms. Most of these observed rhythms reflect both underlying endogenous circadian rhythms and evoked responses from behaviours such as sleep/wake, eating/fasting, rest/activity, posture changes and exercise. For many research and clinical purposes, it is important to understand the contribution of the endogenous circadian component to these observed rhythms.Content: The goal of this manuscript is to provide guidance on best practices in measuring metrics of endogenous circadian rhythms in humans and promote the inclusion of circadian rhythms assessments in studies of health and disease. Circadian rhythms affect all aspects of physiology. By specifying minimal experimental conditions for studies, we aim to improve the quality, reliability and interpretability of research into circadian and daily (i.e., time‐of‐day) rhythms and facilitate the interpretation of clinical and translational findings within the context of human circadian rhythms.We describe protocols, variables and analyses commonly used for studying human daily rhythms, including how to assess the relative contributions of the endogenous circadian system and other daily patterns in behaviours or the environment. We conclude with recommendations for protocols, variables, analyses, definitions and examples of circadian terminology.Conclusion: Although circadian rhythms and daily effects on health outcomes can be challenging to distinguish in practice, this distinction may be important in many clinical settings. Identifying and targeting the appropriate underlying (patho)physiology is a medical goal. This review provides methods for identifying circadian effects to aid in the interpretation of published work and the inclusion of circadian factors in clinical research and practice.


  • Open Access

    Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy

    by Jonathan O. Lipton, Lara M. Boyle, Elizabeth D. Yuan, Kevin J. Hochstrasser, Fortunate F. Chifamba, Ashwin Nathan, Peter T. Tsai, Fred Davis, Mustafa Sahin


  • Sleep and Its Disorders in Childhood

    by Jonathan Lipton, Sanjeev Kothare